Related Experiment Video
Updated: Jun 3, 2025

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
Interaction Between YTH Domain-Containing Family Protein 2 and SET Domain-Containing Lysine Methyltransferase 7
Lexiang Li1, Jun Zhu1, Yi Chen1
1Department of Joint Surgery and Orthopedic Medicine, Shanghai Changzheng Hospital (The Second Affiliated Hospital of Naval Medical University), Shanghai, China.
Background And Objective:
Osteoarthritis (OA) is characterized by progressive cartilage degeneration mediated by various molecular pathways, including inflammatory and autophagic processes. SET domain-containing lysine methyltransferase 7 (SETD7), a methyltransferase, has been implicated in OA pathology. This study investigates the expression pattern of SETD7 in OA and its role in promoting interleukin-1 beta (IL-1β)-induced chondrocyte injury through modulation of autophagy and inflammation.
Methods:
The expression of SETD7 in cartilage tissues from OA patients and healthy controls was quantified using quantitative reverse transcription PCR and Western blot analysis. Small interfering RNA targeting SETD7 (si-SETD7) was transfected into human articular chondrocytes (HACs) treated with IL-1β to examine its impact on cellular viability, apoptosis, inflammatory responses, and autophagy. Functional assays including Cell Counting Kit-8, flow cytometry, enzyme-linked immunosorbent assay, and commercial kits were employed to assess biochemical changes. Interaction between YTH N6-methyladenosine RNA binding protein 2 (YTHDF2) and SETD7 was explored using RNA immunoprecipitation and co-immunoprecipitation assays.
Results:
SETD7 was overexpressed in OA cartilage compared with controls and increased further upon IL-1β treatment. Knockdown of SETD7 in IL-1β-treated HACs improved cellular viability, decreased apoptosis, and reversed the adverse effects on lactate dehydrogenase release and inflammatory markers (tumor necrosis factor-alpha and interleukin-6) while enhancing antioxidant enzymes (catalase, malondialdehyde, and superoxide dismutase). Additionally, autophagy was restored, as evidenced by changes in the levels of autophagy related 5, Beclin1, and sequestosome 1. Interfering with autophagy using chloroquine negated the protective effects of SETD7 knockdown. Furthermore, YTHDF2 was found to stabilize SETD7 mRNA, influencing its expression and enhancing IL-1β-induced chondrocyte injury.
Conclusion:
SETD7 plays a critical role in the pathogenesis of OA by modulating chondrocyte survival, apoptosis, inflammation, and autophagy. The interaction between YTHDF2 and SETD7 exacerbates chondrocyte injury under inflammatory conditions, highlighting potential therapeutic targets for OA treatment. The YTHDF2/SETD7 axis offers a novel insight into the molecular mechanisms governing cartilage degeneration in OA.
Insights
SET domain-containing lysine methyltransferase 7 (SETD7) promotes osteoarthritis (OA) by impairing chondrocyte autophagy and increasing inflammation. Targeting the YTHDF2/SETD7 interaction may offer new therapeutic strategies for OA.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Osteoarthritis (OA) involves cartilage degeneration driven by inflammatory and autophagic pathways.
- SET domain-containing lysine methyltransferase 7 (SETD7) is implicated in OA pathogenesis.
Purpose of the Study:
- Investigate SETD7 expression in OA.
- Determine SETD7's role in interleukin-1 beta (IL-1β)-induced chondrocyte injury.
- Elucidate SETD7's modulation of autophagy and inflammation.
Main Methods:
- Quantified SETD7 expression in OA cartilage via RT-qPCR and Western blot.
- Used si-SETD7 in IL-1β-treated human articular chondrocytes (HACs) to assess viability, apoptosis, inflammation, and autophagy.
- Explored YTHDF2 and SETD7 interaction using RNA immunoprecipitation and co-immunoprecipitation.
Main Results:
- SETD7 was overexpressed in OA cartilage and increased with IL-1β treatment.
- SETD7 knockdown improved chondrocyte viability, reduced apoptosis, and modulated inflammatory markers and antioxidant enzymes.
- SETD7 knockdown restored autophagy, an effect negated by chloroquine; YTHDF2 stabilized SETD7 mRNA.
Conclusions:
- SETD7 critically contributes to OA pathogenesis by affecting chondrocyte survival, apoptosis, inflammation, and autophagy.
- The YTHDF2/SETD7 interaction exacerbates chondrocyte injury in OA.
- The YTHDF2/SETD7 axis presents a novel therapeutic target for OA treatment.
More Related Videos
08:42Real-time Visualization and Analysis of Chondrocyte Injury Due to Mechanical Loading in Fully Intact Murine Cartilage Explants
Published on: January 7, 2019
12:23Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
Published on: April 24, 2020
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Lysosomal Hydrolases
The JAK-STAT Signaling Pathway
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....